Moore A B, May S W
School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332-0400, USA.
Biochem J. 1999 Jul 1;341 ( Pt 1)(Pt 1):33-40.
A series of experiments has been conducted to investigate the possibility that substrate channelling might occur in the bifunctional forms of enzymes carrying out C-terminal amidation, a post-translational modification essential to the biological activity of many neuropeptides. C-terminal amidation entails sequential action by peptidylglycine mono-oxygenase (PAM, EC 1.14.17.3) and peptidylamidoglycolate lyase (PGL, EC 4.3.2.5), with the mono-oxygenase catalysing conversion of a glycine-extended pro-peptide into the corresponding alpha-hydroxyglycine derivative, which is then converted by the lyase into amidated peptide plus glyoxylate. Since the mono-oxygenase and lyase reactions exhibit tandem reaction stereospecificities, channelling of the alpha-hydroxy intermediate might occur, as is the case for some other multifunctional enzymes. Selective inhibition of the mono-oxygenase domain by competitive ester inhibitors, as well as mechanism-based mono-oxygenase inactivation by the novel olefinic inhibitor 5-acetamido-4-oxo-6-phenylhex-2-enoate (N-acetylphenylalanyl acrylate), has little to no effect on the kinetic parameters of the lyase domain of the AE from Xenopus laevis. Similarly, inhibition of the lyase domain by the potent dioxo inhibitor 2,4-dioxo-5-acetamido-6-phenylhexanoate has little effect on the activity of the monooxygenase domain in the bifunctional enzyme. A series of experiments on intermediate accumulation and conversion were also carried out, along with kinetic investigations of the reactivities of the monofunctional and bifunctional forms of PAM and PGL towards substrates and inhibitors. Taken together, the results demonstrate the kinetic independence of the mono-oxygenase and lyase domains, and provide no evidence for substrate channelling between these domains in the bifunctional amidating enzyme.
已经进行了一系列实验,以研究在进行C末端酰胺化的双功能形式的酶中可能发生底物通道化的可能性,C末端酰胺化是许多神经肽生物活性所必需的一种翻译后修饰。C末端酰胺化需要肽基甘氨酸单加氧酶(PAM,EC 1.14.17.3)和肽基酰胺基乙醇酸裂解酶(PGL,EC 4.3.2.5)的顺序作用,单加氧酶催化甘氨酸延伸的前体肽转化为相应的α-羟基甘氨酸衍生物,然后该衍生物被裂解酶转化为酰胺化肽和乙醛酸。由于单加氧酶和裂解酶反应表现出串联反应立体特异性,α-羟基中间体可能会发生通道化,其他一些多功能酶也是如此。竞争性酯抑制剂对单加氧酶结构域的选择性抑制,以及新型烯烃抑制剂5-乙酰氨基-4-氧代-6-苯基己-2-烯酸酯(N-乙酰苯丙氨酰丙烯酸酯)基于机制的单加氧酶失活,对非洲爪蟾AE裂解酶结构域的动力学参数几乎没有影响。同样,强效二氧代抑制剂2,4-二氧代-5-乙酰氨基-6-苯基己酸酯对裂解酶结构域的抑制对双功能酶中单加氧酶结构域的活性影响很小。还进行了一系列关于中间体积累和转化的实验,以及对单功能和双功能形式的PAM和PGL对底物和抑制剂反应性的动力学研究。综合来看,结果表明单加氧酶和裂解酶结构域在动力学上是独立的,并且没有提供双功能酰胺化酶中这些结构域之间底物通道化的证据。